← Leaderboards
Santhi Gorantla
University Of Nebraska Lincoln
$12,360,715
Attributed
$19,303,073
Total exposure
14
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,303,073 · 14
By mechanism
R01$9,845,975 · 4
R24$3,234,988 · 1
R21$1,828,874 · 4
P30$1,365,373 · 1
R33$1,361,774 · 1
N01$862,359 · 1
Top collaborators
- Larisa Y Poluektova12 shared
- Keshore R Bidasee6 shared
- Howard Eliot Gendelman5 shared
- Serguei V Vinogradov5 shared
- Channabasavaiah Gurumurthy2 shared
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelInfectionCellsHumanized MouseBrainAnimal ModelMacrophageTissuesViralMicrogliaAnti-Retroviral AgentsAstrocytesPharmaceutical PreparationsHiv-1VirusChronicAnimalsImmuneNeuronsPeripheralVirus ReplicationViral ReservoirHiv InfectionsVirus Diseases
Grant awards (43)
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2025 · NS · contact PI
Impact of drugs of abuse on HIV brain reservoirs and HAND in humanized microglia mice$538,785
R01 · FY2025 · DA · contact PI
Neurological Disorders in HIV-1 Infection$191,875
R21 · FY2025 · NS
PK/PD and Effect of T-5224 on HIV-1 Transcriptional Activity in an HIV-1-Mouse Model$849,004
N01 · FY2024 · AI · contact PI
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2024 · NS · contact PI
Diastolic Heart Failure in HIV-1 infection$612,681
R01 · FY2024 · HL
Impact of drugs of abuse on HIV brain reservoirs and HAND in humanized microglia mice$538,785
R01 · FY2024 · DA · contact PI
Neurological Disorders in HIV-1 Infection$230,250
R21 · FY2024 · NS
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2023 · NS · contact PI
Diastolic Heart Failure in HIV-1 infection$625,186
R01 · FY2023 · HL
Impact of drugs of abuse on HIV brain reservoirs and HAND in humanized microglia mice$538,785
R01 · FY2023 · DA · contact PI
Examining HIV-mediated disruption of CNS immune homeostasis using a triple humanized mouse$191,875
R21 · FY2023 · MH · contact PI
Enhancement of Human Immune System Development in Mouse Models$191,875
R21 · FY2023 · OD
HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes$690,750
R01 · FY2022 · NS · contact PI
Diastolic Heart Failure in HIV-1 infection$625,186
R01 · FY2022 · HL
Impact of drugs of abuse on HIV brain reservoirs and HAND in humanized microglia mice$538,493
R01 · FY2022 · DA · contact PI
Enhancement of Human Immune System Development in Mouse Models$230,250
R21 · FY2022 · OD
Examining HIV-mediated disruption of CNS immune homeostasis using a triple humanized mouse$230,250
R21 · FY2022 · MH · contact PI
HIV-1 Detection and Elimination From CNS Mononuclear Phagocytes$688,500
R01 · FY2021 · NS · contact PI
Impact of drugs of abuse on HIV brain reservoirs and HAND in humanized microglia mice$537,030
R01 · FY2021 · DA · contact PI
Cell, Tissue and Animal Core$321,705
P30 · FY2021 · MH · contact PI
Preclinical Services for HIV Therapeutics: QA/QC Plan and Task Order Initiation Meeting$13,355
N01 · FY2021 · AI · contact PI
Diastolic dysfunction in HIV infection$586,400
R56 · FY2020 · HL
Cell, Tissue and Animal Core$258,433
P30 · FY2020 · MH · contact PI
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$680,887
R33 · FY2019 · DA · contact PI
Cell, Tissue and Animal Core$258,433
P30 · FY2019 · MH · contact PI
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$680,887
R33 · FY2018 · DA · contact PI
Cell, Tissue and Animal Core$255,744
P30 · FY2018 · MH · contact PI
Center for Humanized Mice$744,154
R24 · FY2017 · OD
Center for Humanized Mice$363,960
R24 · FY2017 · OD
Cell, Tissue and Animal Core$271,058
P30 · FY2017 · MH · contact PI
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$188,128
R21 · FY2017 · DA
Center for Humanized Mice$746,325
R24 · FY2016 · OD
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$186,246
R21 · FY2016 · DA
Center for Humanized Mice$692,358
R24 · FY2015 · OD
CNS Delivery of Activated Antiviral Drugs with Reduced Neurotoxicity (Nano-NRTIs)$371,250
R01 · FY2015 · NS
Humanized Mice as a Tool to Monitor HIV Brain Reservoirs and Effects of Substance Abuse$188,125
R21 · FY2015 · DA
Center for Humanized Mice$688,191
R24 · FY2014 · OD
CNS Delivery of Activated Antiviral Drugs with Reduced Neurotoxicity (Nano-NRTIs)$367,538
R01 · FY2014 · NS
CNS Delivery of Activated Antiviral Drugs with Reduced Neurotoxicity (Nano-NRTIs)$358,256
R01 · FY2013 · NS
CNS Delivery of Activated Antiviral Drugs with Reduced Neurotoxicity (Nano-NRTIs)$371,250
R01 · FY2012 · NS
CNS Delivery of Activated Antiviral Drugs with Reduced Neurotoxicity (Nano-NRTIs)$371,250
R01 · FY2011 · NS
IMMUNE MODULATION AND RESTORATION IN HIV-1 INFECTION$217,330
P20 · FY2009 · RR · contact PI